Recruiting OBSERVATIONAL NCT05474092

Aeson TAH System - Post-Market Clinical Follow-up Study

Evaluation of the Aeson® Total Artificial Heart (TAH) System in a Post-Market Approval Setting

Sponsor: Carmat SAS

Interventions Aeson Total Artificial Heart

Updated 5 times since 2022 Last updated: Jan 27, 2026 Started: Nov 23, 2021 Primary completion: May 31, 2028 Completion: May 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Heart Failure, this trial is actively recruiting participants. The trial is conducted by Carmat SAS and has accumulated 5 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Sep 2024 — Feb 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2023 — Jul 2024 [monthly]

Recruiting
Sep 2022 — Mar 2023 [monthly]

Recruiting

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Carmat SAS

Data source: Carmat SAS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dresden, Germany